Propranolol therapy for cerebral cavernous malformations

Propranolol therapy for cerebral cavernous malformations

Cerebral cavernous malformations (CCMs) are vascular malformations characterized by the abnormal growth of vascular structures in the central nervous system. However, the precise mechanism(s) responsible for the development of CCM vascular abnormalities remain poorly understood. Although the mechani...

Full description

Bibliographic Details
Main Authors: Conde, S.V (Author), Domingues, G. (Author), Gouveia-Fernandes, S. (Author), Hipolito, A. (Author), Lopes-Coelho, F. (Author), Martins, F. (Author), Melo, B.F (Author), Nunes, S. (Author), Pereira, S.A (Author), Sacramento, J.F (Author), Salgado, D. (Author), Serpa, J. (Author), Vinhais, S. (Author)
Format: Article
Language:English
Published: Spandidos Publications 2022
Subjects:
angiogenesis
cerebral cavernous malformation
endothelial cells
monocytes
propranolol
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items